Talphera, Inc. Files 2024 10-K, Reports March 2025 Private Placement
Ticker: TLPH · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1427925
| Field | Detail |
|---|---|
| Company | Talphera, Inc. (TLPH) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financing, subsequent-event
TL;DR
Talphera's 2024 10-K is out. Big news: March 2025 private placement with prefunded warrants. Check it.
AI Summary
Talphera, Inc. (formerly AcelRx Pharmaceuticals Inc.) filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, operating in pharmaceutical preparations, is incorporated in Delaware and headquartered in San Mateo, California. The filing indicates significant subsequent events, including a private placement in March 2025 involving prefunded warrants.
Why It Matters
This 10-K filing provides a comprehensive overview of Talphera's financial health and strategic activities for the past fiscal year, including crucial post-year-end financing events that could impact future operations.
Risk Assessment
Risk Level: medium — The company's reliance on pharmaceutical development and subsequent financing events introduces inherent risks related to market acceptance, regulatory approval, and funding.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-31 — Filing Date (The date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- TALPHERA, INC. (company) — Filer of the 10-K
- ACELRX PHARMACEUTICALS INC (company) — Former name of Talphera, Inc.
- 2024-12-31 (date) — Fiscal year end for the reported period
- 2025-03-31 (date) — Filing date of the 10-K and date of subsequent events
- March 2025 (date) — Period of a significant private placement
FAQ
What was the primary business of Talphera, Inc. during the fiscal year ending December 31, 2024?
Talphera, Inc. is involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was this 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 31, 2025.
What significant event occurred shortly after the fiscal year end?
A private placement occurred in March 2025, involving prefunded warrants and multiple tranches.
What was the former name of Talphera, Inc.?
The former name of Talphera, Inc. was ACELRX PHARMACEUTICALS INC, with a name change date of February 22, 2008.
Where is Talphera, Inc. headquartered?
Talphera, Inc. is headquartered in San Mateo, California, with a business address at 1850 Gateway Drive, Suite 175.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding TALPHERA, INC. (TLPH).